Autor: |
Prevet H; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP, UK., Collins I; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SW7 3RP, UK. |
Jazyk: |
angličtina |
Zdroj: |
Future medicinal chemistry [Future Med Chem] 2019 May; Vol. 11 (10), pp. 1195-1224. |
DOI: |
10.4155/fmc-2018-0370 |
Abstrakt: |
Demonstrating target engagement in living systems can help drive successful drug discovery. Target engagement and occupancy studies in cells confirm direct binding of a ligand to its intended target protein and provide the binding affinity. Combined with biomarkers to measure the functional consequences of target engagement, these experiments can increase confidence in the relationship between in vitro pharmacology and observed biological effects. In this review, we focus on chemically and radioactively labelled probes as key reagents for performing such experiments. Using recent examples, we examine how the labelled probes have been employed in combination with unlabelled ligands to quantify target engagement in cells and in animals. Finally, we consider future developments of this emerging methodology. |
Databáze: |
MEDLINE |
Externí odkaz: |
|